EAU 2013 - Programme Book - YouMed

Monday, 18 March - EAU Programme
Abstract Session
09.15 - 10.45 Prostate cancer biopsies and pathology
Amber Hall 1-2 - Level S2
Poster Session 59
Chairs: F. Gómez Veiga, A Coruna (ES)
V. Scattoni, Milan (IT)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion. Extended presentations (*) are 4 minutes in length, followed
by 2 minutes for discussion.
709 Bimanual examination of retrieved specimen during robot-assisted radical prostatectomy: A novel
technique for reducing the positive surgical margin
W. Jeong, A. Sood, S. Dusik, N.S. Gupta, C.G. Rogers, P. Dasgupta, J.O. Peabody, M. Menon (Detroit, United
States of America; London, United Kingdom)
710 Repeated prostate biopsy: Evaluation of a new diagnostic pathway using mp-MRI, PCA3 and pro-PSA in
the selection of patients
F. Porpiglia, C. Fiori, M. Manfredi, F. Mele, R. Bertolo, S. Grande, F. Russo, D. Regge, E. Bollito, M. Papotti
(Orbassano (Turin), Candiolo (Turin), Italy)
711 Detection of nodal micro-metastases with serial section, immunohistochemistry and real time polymerase
chain reaction in intermediate and high risk prostate cancer patients submitted to radical prostatectomy
with extended pelvic lymph node dissection: A perspective study
R. Schiavina, E. Capizzi, G. Passaretti, D. Romagnoli, A. Bertaccini, E. Brunocilla, F. Manferrari, M. Garofalo,
V. Vagnoni, G.C. Rocca, C.N. Bizzarri, F. Chessa, L. Bianchi, M. Borghesi, M. Fiorentino, G. Martorana
(Bologna, Italy)
712 The novel complexity measures in the objective grading of prostate cancer
P. Waliszewski, M. Tanase, F. Wagenlehner, S. Gattenloehner, W. Weidner (Giessen, Germany; Bucharest,
Romania)
713 Presence of intraductal carcinoma of the prostate on needle biopsy can be a significant prognostic factor
K. Masashi, K. Kyosuke, T. Toyonori, F. Yasuhito, F. Takashi, S. Naoto, M. Yoshihisa, Y. Yasushi, Y. Tokunori,
G. Momokazu (Nagoya, Japan)
714 Spatial distribution of positive cores decreases misclassification rates of patients with low risk prostate
cancer candidate for active surveillance
E. Di Trapani, F. Castiglione, N.M. Passoni, U. Capitanio, A. Gallina, M. Tutolo, M. Bianchi, N. Finocchio,
E. Farina, G. Gandaglia, L. Villa, N. Suardi, V. Mirone, F. Abdollah (Milan, Naples, Italy)
* 715 Can transrectal needle biopsy be optimized to detect nearly all prostate cancer with volume ≥ 0.5 cc? A
three-dimensional analysis
K. Kanao, J.A. Eastham, P.T. Scardino, M. Sumitomo, V.E. Reuter, S.W. Fine (New York, United States of
America; Nagakute, Japan)
716 Biopsy Gleason score ≤ 6. How to predict final pathological specimen Gleason score?
T. Seisen, F. Roudot Thoraval, P.O. Bosset, A. Campeggi, Y. Allory, D. Vordos, A. Hoznek, C-C. Abbou, A. De
La Taille, L. Salomon (Creteil, France)
EAU Milan 2013
241
Monday